Skip to main content

Advertisement

Log in

Candidemia in critically ill patients: difference of outcome between medical and surgical patients

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Candidemia is increasingly encountered in critically ill patients with a high fatality rate. The available data in the critically ill suggest that patients with prior surgery are at a higher risk than others. However, little is known about candidemia in medical settings. The main goal of this study was to compare features of candidemia in critically ill medical and surgical patients.

Design

Ten-year retrospective cohort study (1990–2000).

Setting

Medical and surgical intensive care units (ICUs) of a teaching hospital.

Patients

Fifty-one patients with at least one positive blood culture for Candida species.

Main results

Risk factors were retrieved in all of the patients: central venous catheter (92.1%), mechanical ventilation (72.5%), prior bacterial infection (70.6%), high fungal colonization index (45.6%). Candida albicans accounts for 55% of all candidemia. The overall mortality was 60.8% (85% and 45.2% in medical and surgical patients, respectively). Independent factors associated with survival were prior surgery (hazard ratio [HR] =0.25; 0.09–0.67 95% confidence interval [CI], p<0.05), antifungal treatment (HR =0.11; 0.04–0.30 95% CI, p<0.05) and absence of neutropenia (HR =0.10; 0.02–0.45 95% CI, p<0.05). Steroids, neutropenia and high density of fungal colonization were more frequently found among medical patients compared to surgical ones.

Conclusions

Candidemia occurrence is associated with a high mortality rate among critically ill patients. Differences in underlying conditions could account for the poorer outcome of the medical patients. Screening for fungal colonization could allow identification of such high-risk patients and, in turn, improve outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig.1.

Similar content being viewed by others

References

  1. Beck-Sague C, Jarvis W (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251

    Article  CAS  PubMed  Google Scholar 

  2. Jarvis W, Martone W (1992) Predominant pathogens in hospital infections. J Antimicrob Chemther 29:19–24

    Article  Google Scholar 

  3. Rangel-Frausto M, Wiblin T, Blumberg H, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JJ, Jarvis W, Dawson J, Wenzel R (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253–258

    Article  CAS  PubMed  Google Scholar 

  4. Vincent J, Bihari D, Suter P, Bruining H, White J, Nicolas-Chanoin M, Wolff M, Spencer R, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644

    Article  CAS  PubMed  Google Scholar 

  5. Blumberg H, Jarvis W, Soucie J, Edwards J, Patterson J, Pfaller M, Rangel-Frausto M, Rinaldi M, Saiman L, Wiblin R, Wenzel R (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186

    Article  CAS  PubMed  Google Scholar 

  6. Eubanks P, De Virgilio C, Klein S, Bongard F (1993) Candida sepsis in surgical patients. Am J Surg 166:617–620

    Article  CAS  PubMed  Google Scholar 

  7. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor M, Ibanez-Lucia P, Torres-Rodriguez J (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23:23–30

    Article  CAS  PubMed  Google Scholar 

  8. Petri M, Konig J, Moecke H, Gramm H, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23:317–325

    Article  CAS  PubMed  Google Scholar 

  9. Soutter D, Todd T (1986) Systemic candidiasis in a surgical intensive care unit. Can J Surg 29:197–199

    CAS  PubMed  Google Scholar 

  10. Tang E, Tang G, Berne T (1993) Prognostic indicators in fungemia of the surgical patients. Arch Surg 128:759–763

    Article  CAS  PubMed  Google Scholar 

  11. Borzotta A, Beardsley K (1999): Candida infections in critically ill trauma patients. Arch Surg 134:657–665

    Article  CAS  PubMed  Google Scholar 

  12. Pittet D, Monod M, Suter P, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Voss A, le Noble J, Verduyn Lunel F, Foudraine N, Meis J (1997) Candidemia in intensive care unit patients: risk factors for mortality. Infection 25:8-11

    Article  CAS  PubMed  Google Scholar 

  14. Hadley S, Lee W, Ruthazer R, Nasraway SJ (2002) Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients. Crit Care Med 30:1808–1814

    Article  PubMed  Google Scholar 

  15. Komshian S, Uwaydah A, Sobel J, Crane L (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 11:379–390

    Article  CAS  PubMed  Google Scholar 

  16. Blot S, Vandewoude K, Hoste E, Colardyn F (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480–485

    Article  PubMed  Google Scholar 

  17. Pelz R, Hendrix C, Swoboda S, Diener-West M, Merz W, Hammonds J, Lipsett P (1999) A double blind placebo controlled trial of prophylactic fluconazole to prevent candida infections in critically ill surgical patients. Crit Care Med 27: A33

    Google Scholar 

  18. Ables A, Blumer N, Valainis G, Godeaick M, Palesh Y (1998) Fluconazole prophylaxis of severe infection in trauma and post-surgical patients. Crit Care Med 26:52A

    Article  Google Scholar 

  19. Eggimann P, Francioli P, Bille J, Schneider R, Wu M, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser M, Calandra T (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072

    Article  CAS  PubMed  Google Scholar 

  20. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28:1708–1717

    Article  PubMed  Google Scholar 

  21. Le Gall J, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963

    Article  Google Scholar 

  22. Bone R (1993) The pathogenesis of sepsis. Ann Intern Med 115:457–469

    Article  Google Scholar 

  23. Vincent J, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom P, Pittet D, Rogers T, Sandven P, Sganga G, Schaller M, Solomkin J (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–216

    Article  CAS  PubMed  Google Scholar 

  24. Richet H, Roux P, Des Champs C, Esnault Y, Andremont A, Group FCS (2002) Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8:405–412

    Article  CAS  PubMed  Google Scholar 

  25. Pittet D, Li N, Woolson R, Wenzel R (1997) Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 24:1068–1078

    Article  CAS  PubMed  Google Scholar 

  26. Wey S, Mori M, Pfaller M, Woolson R, Wenzel R (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645

    Article  CAS  PubMed  Google Scholar 

  27. Harvey R, Myers J (1987) Nosocomial fungemia in a large teaching hospital. Arch Intern Med 147:2117–2120

    Article  CAS  PubMed  Google Scholar 

  28. Craven D, Kunches L, Lichtenberg D, Kollisch N, Barry M, Heeren T, McCabe W (1988) Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 148:1161–1168

    Article  CAS  PubMed  Google Scholar 

  29. Winston D, Chandrasekar P, Lazarus H, Goodman J, Silber J, Horowitz H, Shadduck R, Rosenfeld C, Ho W, Islam M (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 118:495–503

    Article  CAS  PubMed  Google Scholar 

  30. Goodman J, Winston D, Greenfield R, Chandrasekar P, Fox B, Kaizer H, Shadduck R, Shea T, Stiff P, Friedman D (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845–851

    Article  CAS  PubMed  Google Scholar 

  31. Desai M, Rutan R, Heggers J, Herndon D (1992) Candida infection with and without nystatin prophylaxis. An 11-year experience with patients with burn injury. Arch Surg 127:159–162

    Article  CAS  PubMed  Google Scholar 

  32. Bow E, Laverdiere M, Lussier N, Rotstein C, Cheang M, Ioannou S (2002) Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta-analysis of randomized-controlled clinical trials. Cancer 94:3230–3246

    Article  CAS  PubMed  Google Scholar 

  33. Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967

    Article  CAS  PubMed  Google Scholar 

  34. Rutledge R, Mandel S, Wild R (1986) Candida species. Insignificant contaminant or pathogenic species. Am Surg 52:299–302

    CAS  PubMed  Google Scholar 

  35. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P (1989) Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 2:1437–1440

    Article  CAS  PubMed  Google Scholar 

  36. Alverdy J, Aoys E (1991) The effect of glucocorticoid administration on bacterial translocation. Evidence for an acquired mucosal immunodeficient state. Ann Surg 214:719–723

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tancrede C, Andremont A (1985) Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152:99–103

    Article  CAS  PubMed  Google Scholar 

  38. Cirera I, Bauer T, Navasa M, Vila J, Grande L, Taura P, Fuster J, Garcia-Valdecasas J, Lacy A, Suarez M, Rimola A, Rodes J (2001) Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 34:32–37

    Article  CAS  PubMed  Google Scholar 

  39. Anaissie E, Rex J, Uzun O, Vartivarian S (1998) Predictors of adverse outcome in cancer patients with candidemia. Am J Med 104:238–245

    Article  CAS  PubMed  Google Scholar 

  40. Slotman G, Shapiro E, Moffa S (1994) Fungal sepsis: multisite colonization versus fungemia. Am Surg 60:107–113

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pierre Emmanuel Charles.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Charles, P.E., Doise, J.M., Quenot, J.P. et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29, 2162–2169 (2003). https://doi.org/10.1007/s00134-003-2002-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-2002-x

Keywords

Navigation